Contribution of Autonomic Reflexes to the Hyperadrenergic State in Heart Failure.

Front Neurosci

Department of Internal Medicine, Fondazione IRCCS Ca' Granda Ospedale Maggiore PoliclinicoMilan, Italy.

Published: March 2017

Heart failure (HF) is a complex syndrome representing the clinical endpoint of many cardiovascular diseases of different etiology. Given its prevalence, incidence and social impact, a better understanding of HF pathophysiology is paramount to implement more effective anti-HF therapies. Based on left ventricle (LV) performance, HF is currently classified as follows: (1) with reduced ejection fraction (HFrEF); (2) with mid-range EF (HFmrEF); and (3) with preserved EF (HFpEF). A central tenet of HFrEF pathophysiology is adrenergic hyperactivity, featuring increased sympathetic nerve discharge and a progressive loss of rhythmical sympathetic oscillations. The role of reflex mechanisms in sustaining adrenergic abnormalities during HFrEF is increasingly well appreciated and delineated. However, the same cannot be said for patients affected by HFpEF or HFmrEF, whom also present with autonomic dysfunction. Neural mechanisms of cardiovascular regulation act as "controller units," detecting and adjusting for changes in arterial blood pressure, blood volume, and arterial concentrations of oxygen, carbon dioxide and pH, as well as for humoral factors eventually released after myocardial (or other tissue) ischemia. They do so on a beat-to-beat basis. The central dynamic integration of all these afferent signals ensures homeostasis, at rest and during states of physiological or pathophysiological stress. Thus, the net result of information gathered by each controller unit is transmitted by the autonomic branch using two different codes: and of sympathetic discharges. The main scope of the present article is to (i) review the key neural mechanisms involved in cardiovascular regulation; (ii) discuss how their dysfunction accounts for the hyperadrenergic state present in certain forms of HF; and (iii) summarize how sympathetic efferent traffic reveal central integration among autonomic mechanisms under physiological and pathological conditions, with a special emphasis on pathophysiological characteristics of HF.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5372354PMC
http://dx.doi.org/10.3389/fnins.2017.00162DOI Listing

Publication Analysis

Top Keywords

hyperadrenergic state
8
heart failure
8
neural mechanisms
8
cardiovascular regulation
8
contribution autonomic
4
autonomic reflexes
4
reflexes hyperadrenergic
4
state heart
4
failure heart
4
failure complex
4

Similar Publications

Pathophysiology and management of postural orthostatic tachycardia syndrome (POTS): A literature review.

Curr Probl Cardiol

December 2024

Department of Cardiovascular Medicine, National Kapodistrian University of Athens, Athens, Greece; Department of Cardiovascular Medicine, Section of Heart Failure and Transplantation, University of Iowa, Iowa City, IA, USA. Electronic address:

Postural Orthostatic Tachycardia Syndrome (POTS) is a form of cardiovascular autonomic disorders characterized by orthostatic intolerance and a symptomatic increase in heart rate upon standing, which can significantly impair patients' quality of life. Its pathophysiology is complex, multifactorial; thus, a variety of treatment approaches have been investigated. Recent studies have identified three primary POTS phenotypes-hyperadrenergic, neuropathic, and hypovolemic-each requiring tailored management strategies.

View Article and Find Full Text PDF

Metabolic targets in the Postural Orthostatic Tachycardia Syndrome: A short thematic review.

Auton Neurosci

December 2024

Department of Exercise Science, Syracuse University, Syracuse, NY, United States. Electronic address:

Postural Orthostatic Tachycardia Syndrome (POTS) is a chronic autonomic condition hallmarked by orthostatic intolerance and tachycardia in the upright position. POTS impacts approximately 1-3 million people in the U.S.

View Article and Find Full Text PDF

Hyperadrenergic Postural Tachycardia Syndrome: Clinical Biomarkers and Response to Guanfacine.

Hypertension

November 2024

Vanderbilt Autonomic Dysfunction Center, Division of Clinical Pharmacology (L.E.O., V.U., S.R., M.G., C.A.S., A.D., I.B.), Vanderbilt University Medical Center, Nashville, TN.

Article Synopsis
View Article and Find Full Text PDF

Glycyrrhizic acid induced acquired apparent mineralocorticoid excess syndrome with a hyperadrenergic state: a case report.

J Med Case Rep

August 2024

Division of Nephrology, UMass Chan Medical School, Baystate Medical Center, 759 Chestnut St., Springfield, MA, 01199, USA.

Article Synopsis
  • * A case study details a 65-year-old woman who experienced severe hypertension, low potassium levels, and adrenergic symptoms after taking a supplement containing licorice, leading to a diagnosis of acquired AME.
  • * Stopping the supplement resulted in the patient's complete recovery, highlighting the need to be cautious about glycyrrhizic acid in unregulated supplements and its potential to cause AME.
View Article and Find Full Text PDF

Chronic fatigue syndrome (CFS) is a heterogeneous disorder with a genetically associated vulnerability of the catecholamine metabolism (e.g., catechol O-methyltransferase polymorphisms), in which environmental factors have an important impact.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!